Sekyi-Brown Reginald: Ghana Should Include Alteplase and Tenecteplase in National Health Insurance
Sekyi-Brown Reginald, Chairperson at Early Career Pharmaceutical Group, Ghana, Franchise Manager at Pharmasymbiosis, shared on LinkedIn about a recent article by Samuel Darkwah et al, published in Stroke Research and Treatment:
”Rethinking Emergency Medicine in Ghana
Darkwah et al intimate that Stroke ranks amongst the top 3 causes of death and disability in Ghana in their 2025 situational analysis of Stroke in Ghana.
Ghana has to seriously consider including alteplase/tenecteplase in its National Health Insurance List.
Given the fact that it has been part of the World Health Organization’s Essential medicines list since 2019.
Although the current NHIS list captures Streptokinase; the evolution of medicine requires that our Essential Medicines List reflects the reality of modern clinical practice.
Even more importantly, the new STROKE guideline prominently recommends Alteplase and Tenecteplase makes it even more timely.
For a country that spends millions on healthcare; making a conscious effort to include such critical medicines is long overdue.”
Title: Stroke in Ghana: A Situational Analysis
Authors: Samuel Darkwah, Aaron Awere-Duodu, Bismark Opoku-Asare, Eric S. Donkor
Read the Full Article on Stroke Research and Treatment
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS